CDCN
@CureCastleman
Followers
1K
Following
475
Media
210
Statuses
911
Castleman Disease Collaborative Network: turning promising research into permanent cures. Donate today at https://t.co/2Y2h2XN0uN
Joined July 2014
RT @AAMCtoday: As a med student, @DavidFajgenbaum nearly died several times from Castleman’s disease, a rare condition with no known treatm….
aamc.org
David Fajgenbaum, MD, nearly died from a rare disease, but his own research unearthed a treatment. Now he’s using AI and groundbreaking research to help others.
0
10
0
The new @WHO Classification of Haematolymphoid Tumours includes a section on Castleman disease for the first time ever thanks to the CDCN SAB's Amy Chadburn, David Fajgenbaum, and Megan Lim!. Explore this resource on diagnosing and treating CD here:
0
0
0
RT @DavidFajgenbaum: What does Nobel Prize Winner Dr. Drew Weissman think of drug repurposing?. Like us, he thinks it’s a no brainer!. Deve….
0
14
0
I’m going to have an identity crisis! . Should I be the LeCount Disease Collaborative Network?!.
…but a recent paper came out indicating that Dr. Edwin LeCount may have actually first described it in 1899! Should it be called LeCount’s disease?!?
0
1
4
We love #drugrepurposing for #castleman disease, but this is our favorite one….
Really exciting to see this study reporting the effectiveness of sirolimus in a large cohort of idiopathic multicentric castleman disease patient!. . I discovered sirolimus could be a treatment for iMCD in 2014 and began testing it on myself….
0
0
3
RT @SALASeries: On our continued to-do list: support @DavidFajgenbaum and @EveryCure as they help alleviate suffering for the 300M people g….
0
3
0
In this study, researchers at the Center for Cytokine Storm Treatment & Laboratory (CSTL) at Penn shed light on the burden faced by patients with idiopathic multicentric Castleman disease (IMCD) at diagnosis and long-term.
0
0
1
Researchers at the Cytokine Storm Treatment & Laboratory (CSTL) share insights into idiopathic multicentric Castleman disease (iMCD) and its subtypes that could potentially lead to patients benefiting from more personalized, tailored treatments.
onlinelibrary.wiley.com
Idiopathic multicentric Castleman disease (iMCD) is a haematological illness that presents with a wide range of clinical characteristics and is subdivided into three subtypes: thrombocytopenia,...
0
0
1
RT @thephilacitizen: From block captains to corporate leaders, we are privileged to have celebrated the diverse changemakers honored at The….
thephiladelphiacitizen.org
The inaugural Philadelphia Citizen of the Year Awards were a joyful celebration what it means to be a good citizen
0
4
0
RT @DavidFajgenbaum: Thinking back 13 years ago when I was fighting for my life in the ICU, I thought that there was no chance that I would….
0
8
0
RT @EricTopol: My top 10 books for 2023.@abe_verghese @peteratmsr @mustafasuleyman @DoctorChrisVT @PeterAttiaMD @kkariko @drfeifei @PeterHo….
0
152
0
RT @DavidFajgenbaum: Great to see our collaborative work/discovery between @EveryCure, @Penn, and @CureCastleman selected as one of the top….
labiotech.eu
2023 has been an exciting year for the industry. Here are some of the most notable biotech developments in 2023.
0
7
0
Love seeing this profile on @LinkedInNews about our co-founder, @DavidFajgenbaum!.
I am beyond honored to be featured in @LinkedInNews Catalyst Series that highlights our journey #ChasingMyCure, the power of #horizontalthinking, and the amazing work my teams are doing at @EveryCure , @CureCastleman, @PennMedicine .
0
0
2
RT @DavidFajgenbaum: So great to be at the @ASH_hematology annual meeting where we’re holding our annual @CureCastleman workshop and our t….
cdcn.org
The CDCN holds an annual "Accelerating research & treatment for Castleman disease" meeting at the American Society of Hematology in San Diego, CA.
0
4
0
RT @DavidFajgenbaum: So good to see @doctorpemm at @ASH_hematology! Can’t wait for our annual #castleman meeting tonight!. #castlemanwarrio….
0
3
0
RT @DavidFajgenbaum: New drug development is like starting at your own 1-yard line with a 10% chance of driving down the field to score big….
0
7
0
RT @DavidFajgenbaum: My passion for finding new uses for existing drugs started long before #chasingmycure. While my mom was battling brain….
0
4
0
RT @DavidFajgenbaum: Thank you to @AJMC_Journal for featuring @EveryCure, in its latest documentary about rare disease treatment gaps! . A….
0
5
0
RT @DavidFajgenbaum: Ancient drug reduces heart attacks? . In this clip from the @Medscape Podcast, Dr. @EricTopol and I discuss Colchicin….
0
15
0